Benzathine Penicillin G Treatment for TPHA-Positive Female
A TPHA-positive female should receive benzathine penicillin G 2.4 million units intramuscularly as a single dose for primary, secondary, or early latent syphilis, or three weekly doses of 2.4 million units for late latent syphilis or syphilis of unknown duration 1.
Treatment Algorithm Based on Syphilis Stage
For Primary, Secondary, or Early Latent Syphilis
- Single dose: 2.4 million units IM once 1, 2
- Recent high-quality evidence from 2025 demonstrates that one dose is noninferior to three doses for early syphilis, with 76% serologic response at 6 months 2
- This applies regardless of HIV status 2
For Late Latent or Unknown Duration Syphilis
- Three doses: 2.4 million units IM weekly for 3 consecutive weeks 1, 3
- This extended regimen is necessary because late syphilis requires prolonged treponemicidal coverage
Critical Considerations for Pregnancy
If the patient is pregnant, the treatment approach requires modification:
- Minimum two doses (preferably three) of 2.4 million units IM at weekly intervals 4
- Single-dose therapy in pregnancy has shown significantly worse outcomes: increased prematurity (RR 8.5), perinatal mortality (RR 20.5), and lower birth weight 4
- Treatment should ideally be completed at least 4 weeks before delivery 4
- This is especially critical if:
- Presenting before 28 weeks gestation
- Initial RPR titer >16 4
The evidence strongly contradicts single-dose therapy in pregnancy, even though it may be adequate for non-pregnant individuals with early syphilis 4.
Administration Technique
- Deep intramuscular injection in upper outer quadrant of buttock (dorsogluteal) or ventrogluteal site 1
- Inject slowly and steadily due to high concentration of suspended material 1
- Never inject intravenously, near arteries or nerves 1
Expected Jarisch-Herxheimer Reaction
Counsel the patient that approximately 1 in 4 patients (23.7%) will experience JHR symptoms 5:
- Onset typically within 4.9 hours (86% within 12 hours) 5
- Duration approximately 12.8 hours 5
- Most common symptoms: myalgias (51%), chills (46%), weakness (39%), feverishness (36%) 5
- JHR is actually associated with better treatment outcomes (85% vs 69% serologic response) 5
- More common with secondary syphilis and in HIV-negative patients 5
Follow-Up Requirements
- Clinical and serologic evaluation at 6 and 12 months 6
- Expect nontreponemal titers (RPR/VDRL) to decline by ≥2 dilutions or become nonreactive 6
- If pregnant, repeat VDRL every trimester and renew therapy if titers don't significantly decrease 3
Penicillin Allergy Management
If true penicillin allergy is documented:
- Desensitization is mandatory for pregnant women - no alternatives are acceptable 6
- For non-pregnant patients: doxycycline 100 mg orally twice daily for 14 days is the preferred alternative 6
- Avoid azithromycin due to documented resistance 6
Common Pitfalls to Avoid
- Do not use single-dose therapy in pregnancy - this is the most critical error, associated with 20-fold increased perinatal mortality 4
- Do not assume TPHA-positive alone means active infection - confirm with nontreponemal test (RPR/VDRL) to determine if treatment is needed 6
- Do not forget HIV testing - all syphilis patients require HIV screening 6
- Do not use anterolateral thigh injection site - associated with adverse effects 1